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Summary: We propose a C-index (index of concordance) applicable to recurrent event data. The
present work addresses the dearth of measures for quantifying a regression model’s ability to dis-
criminate with respect to recurrent event risk. The data which motivated the methods arise from the
Dialysis Outcomes and Practice Patterns Study (DOPPS), a long-running prospective international
study of end-stage renal disease patients on hemodialysis. We derive the theoretical properties of
the measure under the proportional rates model (Lin et al., 2000), and propose computationally
convenient inference procedures based on perturbed influence functions. The methods are shown
through simulations to perform well in moderate samples. Analysis of hospitalizations among a
cohort of DOPPS patients reveals substantial improvement in discrimination upon adding country
indicators to a model already containing basic clinical and demographic covariates, and further
improvement upon adding a relatively large set of comorbidity indicators.
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1. Introduction
In the analysis of clinical or epidemiologic data, the event of interest is often recurrent (i.e.,
can occur multiple times for the same subject). Examples of recurrent events include hospital
admissions, infections, relapses and blood transfusions. Methods of analysis of recurrent event
data can be broadly classified as marginal or conditional, the distinction being that marginal
methods implicitly average over the prior recurrent event history. Conditional models are
distinguished by conditioning on the event history, either implicitly (e.g., through a frailty
variate correlating the events within-subject) or explicitly through time-dependent covariates
(e.g., event counters). Examples of marginal methods include Lawless and Nadeau (1995),
Lin et al. (2000), and Schaubel et al. (2006), while examples of conditional methods include
Andersen and Gill (1982). A comprehensive review of recurrent event models and methods
is given by Cook and Lawless (2007).
The data which motivated our current work arise from the renown Dialysis Outcomes and
Practice Patterns Study (DOPPS). The DOPPS is a prospective, multi-center, international
study of patients receiving hemodialysis (the most common form of dialysis). Note that
dialysis is the most common form of renal replacement therapy (RRT), which is necessary for
patients with end-stage renal disease (ESRD), a condition characterized by kidney function
that has diminished to such an extent that survival is considered impossible without RRT.
The DOPPS has been ongoing for more than 20 years, with data collected through five
Phases. Details regarding the design of the DOPPS study have been described by Young
et al. (2000). In Section 5, we analyze data from DOPPS Phase 5, which is the most recently
completed phase. The recurrent event of interest is hospitalization, which is an important
event due to its connection with morbidity and mortality, patient quality of life, health care
cost and resource utilization. Since the DOPPS contains patients from many countries, we
have a rather unique ability to directly evaluate differences among countries with respect to
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hospitalization rates. Correspondingly, we place some focus on comparing covariate-adjusted
hospitalization rates by country. Of chief interest is evaluating the degree to which the fitted
model accurately discriminates hospitalization risk among patients.
With respect to time-to-event outcomes, the majority of analyses have focused on patient
survival. Furthermore, the limited number of DOPPS studies evaluating outcomes that can
occur repeatedly within patient (e.g., hospitalization) have generally been restricted to time
to first event. For example, in the study of hospitalizations, the event time would be time to
first admission. Perhaps the biggest disadvantage of using time-to-first-event is inefficiency,
in that considerable precision is sacrificed by ignoring each patient’s second and subsequent
events. That said, a benefit (or, at least a perceived benefit) of time-to-first-event is the
ability to utilize techniques which are well-established for univariate survival data, but less
(or not) developed for recurrent events. Among the more prominent techniques are those for
model discrimination. The C-index (also known as the index of concordance) has become
the most frequently used measure of the discriminatory ability of a survival model. However,
no such measure has been developed for recurrent event data.
Considerable advancement has been made in the last 15 years with respect to the breadth
of analyses available for recurrent event data. The majority of such works has focused on
developing recurrent event methods for more complicated data structures. For example,
Miloslavsky et al. (2004) developed recurrent event methods for dependently censored data.
Several methods have been developed for jointly analyzing recurrent/terminal event data;
e.g., Ghosh and Lin (2002), Huang and Wang (2004), Liu et al. (2004), and Ye et al. (2007).
Despite the continuing advances in recurrent event methodology, there are relatively few
methods available for evaluating a fitted model. The degree of fit is generally described in
terms of predictive accuracy and/or discrimination ability, where the former considers how
closely the fitted values approximate the observed responses. Discrimination considers the
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extent to which a model accurately distinguishes higher and lower risk subjects, and could
be argued to be the more relevant of the two criteria in settings where prediction, per se,
is not the analytic objective. A frequently used discrimination measure is the C-index. The
C-index is related to the area under the receiver-operating curve (ROC), and was considered
in the context of censored data by authors such as Harrell et al. (1982, 1984, 1996) and Uno
et al. (2007). Several methods have been developed for ROC curves for survival data; e.g.,
Heagerty et al. (2000), Moskowitz and Pepe (2004), Heagerty and Zheng (2005), and Uno
et al. (2011).
In this report, we propose a C-index applicable to recurrent event data. Although initially
motivated by a need to evaluate the discriminatory ability of the proportional rates model
to the DOPPS data, the work addresses the lack of a widely accepted measure of model
discrimination when the response is a recurrent event. The C-index can be interpreted as
the proportion of subject-pairs for which the survival time ordering is concordant with the
ordering of the fitted model’s linear predictor. In the presence of censoring, the denominator
of the C-index is the number of subject-pairs for which the order of the failure times is
observed. Applying this concept to recurrent event responses, two subjects are comparable
during follow-up time intervals during which both subjects are uncensored. For example,
in the presence of right censoring and absence of any left truncation, two subjects are
comparable until the minimum of the two censoring times; the subject pair then contributes
to the denominator if the two event counters are not tied (at 0 or otherwise).
Using counting processes and U-processes theories, we derive the large-sample distribution
of the proposed C-index estimator, and then propose a simulation-based method for comput-
ing standard errors and hence confidence intervals. Due to its popularity among practitioners,
we derive the theoretical properties of the proposed C-index assuming the proportional rates
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model of Lin et al. (2000); extension of our results to other models, such as the additive rates
model (Schaubel et al., 2006), would be straightforward.
The remainder of this report is organized as follows. In Section 2, we notationalize the
data structure and set out the proposed measure. In Section 3, we derive the theoretical
properties, proofs for which appear in the Appendix. Simulations are carried out in Section
4. The proposed methods are applied to the afore-described DOPPS data in Section 5. In
Section 6, we provide some discussion.
2. Proposed Methods
2.1 Set-up and Notation
Let N∗(t) denote the number of events that occur over the interval [0, t] and C denote the
follow-up or censoring time. Assume that N∗(·) and C are independent conditional on a p-
dimensional covariate vector Z. The observed event process is denoted as N(t) = N∗(t ∧C)
over the total observation window [0, τ ], where a ∧ b = min(a, b). In the set-up of interest,
we have a random sample of n individuals, with observed data {Ni(t), Ci,Zi; 0 6 t 6 τ}
(i = 1, . . . , n).
The proportional rates/means model (Lin et al., 2000) is commonly used to analyze
recurrent event data. This model formulates the mean function for N∗(·) is associated with
covariates Z as follows,
µZ(t) ≡ E{N∗(t)|Z} = µ0(t) exp(β0′Z), (1)
where µ0(·) is an unknown baseline mean function of the marginal recurrent event process,
and β0 is an unknown vector of regression parameters. The estimating equation for β0 is
given by
U(β) =
n∑
i=1
Ui(β) =
n∑
i=1
∫ τ
0
{
Zi −
∑
k Yk(t)Zk exp(β
′Zk)∑
k Yk(t) exp(β
′Zk)
}
dNi(t) = 0, (2)
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where Yi(t) = I(Ci > t) and I(·) is the indicator function. The solution of (2) is βˆ, and the
Aalen-Breslow-type estimator for µ0(t) is µˆ(t).
2.2 Proposed C-index for Recurrent Events
Consider future observations on two independent patients indexed k = 1 and k = 2 with
observed data {N˚∗k (C˚k), C˚k, Z˚k} for k = 1, 2. A natural way to evaluate the risk discrim-
ination ability of a recurrent event rate/mean model is to measure concordance between
the observed and predicted event counts over the time interval of common observation; i.e.,
µˆZ1(C˚1 ∧ C˚2) versus µˆZ2(C˚1 ∧ C˚2), given N˚∗1 (C˚1 ∧ C˚2) and N˚∗2 (C˚1 ∧ C˚2). We consider event
rate models which are monotone functions of the linear predictor, β′Z˚k. Without loss of
generality, assuming that µZk(t) is monotone increasing in β
′Z˚k, we propose summarizing
the model’s risk discrimination through the following C-index,
C(β) = Pr{β′Z˚1 > β′Z˚2|N˚∗1 (C˚1 ∧ C˚2) > N˚∗2 (C˚1 ∧ C˚2)}. (3)
Note that β may be derived from a score obtained from the existing literature, in which case
β in (3) could be replaced by a constant vector β0 to reflect the fact that the parameter
implied by the score is known with certainty. Conversely, the basis of the score may be an
event rate model fitted to the data at hand, such that β from (3) would be replaced by an
estimate βˆ to reflect its randomness. In the development that follows, we focus on the latter
case, keeping in the background the various simplifications that arise when β0 is known.
We propose that (3) be estimated by the proportion of pairs in which the risk prediction
scores and the observed event counts are concordant, as given by
Cˆ(β) =
∑n
i=1
∑n
j=1 I{Ni(Ci ∧ Cj) > Nj(Ci ∧ Cj)}I(β
′
Zi > β
′
Zj)∑n
i=1
∑n
j=1 I{Ni(Ci ∧ Cj) > Nj(Ci ∧ Cj)}
. (4)
It is interesting to compare Cˆ(β) for recurrent event data to a concordance index for
survival data where a subject can have at most one event (e.g., death or time-to-first recurrent
event). Let Ti be the time-to-first event for the ith subject, with Xi = Ti∧Ci as the observed
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survival time, and set ∆i = I(Ti < Ci). For right-censored survival data, Harrell et al. (1996)
proposed a concordance index, which can be rewritten using counting process notation as
follows,
CˆS(β) =
∑n
i=1
∑n
j=1∆i I(Xi < Xj, β
′
Zi > β
′
Zj)∑n
i=1
∑n
j=1∆i I(Xi < Xj)
(5)
=
∑n
i=1
∑n
j=1 I{Ni(Xi ∧Xj) > Nj(Xi ∧Xj)}I(β
′
Zi > β
′
Zj)∑n
i=1
∑n
j=1 I{Ni(Xi ∧Xj) > Nj(Xi ∧Xj)}
.
In survival data, a simple derivation can show that Cˆ(β) = CˆS(β). However, when subjects
can experience multiple (recurrent) events, restricting responses to ‘time-to-first event’ can
result in reduced discriminatory power (i.e., CˆS < Cˆ). See Table 5 for an example.
We note that Cˆ(βˆ) converges in probability to a censoring-dependent quantity
C0 = Pr{β′0Z˚1 > β′0Z˚2|N˚∗1 (C˚1) > N˚∗2 (C˚1), C˚1 6 C˚2},
provided that βˆ converges to a constant vector β0 as n goes to infinity. It is true regardless
whether the model (1) holds. For right-censored survival data, Gerds et al. (2013) showed that
Harrell’s estimator CˆS, which does not explicitly model the censoring mechanism, performed
as well as several existing Inverse Probability of Censoring Weighted C-index estimators.
Correspondingly, our simulation study also showed a good performance of the proposed C-
index even under violation f the assumption of conditionally independent censoring given
the predictors. Therefore, in the interests of practicality and computational simplicity, we
consider an unweighted version of the C-index.
The proposed C-index, Cˆ(βˆ), discriminate event risk between subjects based on the esti-
mated linear predictor, βˆ
′
Z, from a regression model. However, as implied earlier, an external
score determined independently of the data at hand could also be used. Examples include
quantities such as the Gail model for breast cancer risk (Gail and Mai, 2010); the Model
for End-Stage Liver Disease (MELD) score (Wiesner et al., 2003); and the Kidney Donor
Risk Index (KDRI) for deceased-donor kidneys (Rao et al., 2009). From this perspective,
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the true value, C0, simply represents the limiting value of the Cˆ with respect to a particular
score, irrespective of whether the risk score is based on the true model (or any model). If an
externally derived score is the basis of risk discrimination, a consistent variance estimator
can be obtained based on the first term in equation (6).
2.3 Variance Estimation
In the Appendix, we show that W = √n {Cˆ(βˆ) − C0} is asymptotically normal with mean
zero and variance σ2. To estimate σ2, we use a resampling-based method. In particular, we
modify the perturbation resampling method by Uno et al. (2011) to the recurrent event
setting. Specifically, we first formulate W ∗, a perturbed version of W , then show that it has
the same limiting distribution as W . Then, σ2 can be estimated as the sample variance on
B realizations of W ∗.
First, we construct a perturbed W ∗ that depends on two sources of random variation,
βˆ and Cˆ(β) for a fixed β. Perturbation of both sources can be done by the same random
quantity, resampled from any known distribution with mean 1 and variance 1. For instance,
we use ǫ ∼ Exponential(1). By (repeatedly) generating a random variable {ǫi; i = 1, . . . , n},
a perturbed βˆ can be obtained by
β∗ = βˆ +
(
n
2
)
−1∑
i<j
Aˆ−1(βˆ){Ui(βˆ) + Uj(βˆ)} ǫiǫj/2,
where Aˆ(β) = −n−1∂U(β)/∂β. The βˆ perturbation is done through the estimating equation
for β0 in equation (2). To generate a perturbed counterpart of Cˆ(β), we define
Vij(β) =
I{Ni(Ci ∧ Cj) > Nj(Ci ∧ Cj)}{I(β′Zi > β′Zj)− Cˆ(β)}
n−2
∑n
i=1
∑n
j=1 I{Ni(Ci ∧ Cj) > Nj(Ci ∧ Cj)}
.
Then, a perturbed random variable W ∗ can be generated by
W ∗ =
√
n
(
n
2
)
−1∑
i<j
{Vij(βˆ) + Vji(βˆ)} ǫiǫj/2 +
√
n {Cˆ(β∗)− Cˆ(βˆ)}. (6)
Finally, a two-sided 95% confidence interval can be obtained by Cˆ(βˆ)± 1.96 σˆ/√n, where σˆ
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is the sample standard deviation of W ∗, following the asymptotic normality of W ∗ shown in
the Appendix.
We note that the second term of (6) needs to assume that the risk prediction model
(at least the regression components) is correctly specified. This assumption can be avoided
by employing the nonparametric bootstrap. This gain in robustness is at the expense of
increased computation time. For instance, in our analysis of the DOPPS data (Section 4),
the model-based standard error estimates using (6) were very similar to the nonparametric
bootstrap estimates (see Tables 5 - 6), but took one third of the computing time required
for the nonparametric bootstrap.
3. Simulation
We evaluated the finite sample properties of the proposed estimator in (4) through a series
of simulation studies under scenarios which differed by the intensity of recurrent events and
the censoring mechanism. The recurrent event times were generated from a proportional
intensity model:
ΛZi(t) = Λ0(t)γi exp(β1Z1i + β2Z2i), (7)
where Z1i ∼ Uniform[−1, 1], Z2i ∼ Bernoulli(0.5), and true (β1, β2)′ = (1, 0.5). To vary the
intensity of recurrent events, we included a subject-specific random effect γi, following a
Gamma distribution with mean 1 and variance V = 0.01, 0.25, 0.5, or 1. As the V value
increased, an individual tended to experience more events, but a percentage of individuals
with zero event also increased. Hence a total number of observed events was similar across
different V values. To investigate sensitivity to the assumption on the censoring mechanism,
the censoring time Ci was generated from the following four scenarios:
1) Complete follow-up: Ci = τ for all i; set τ = 5
2) Completely independent censoring
Page 9 of 27 Biometrics
Au
tho
r M
an
us
cri
pt
C-index for Recurrent Event Data 9
3) Covariate-dependent censoring
4) Outcome-dependent censoring
In Scenario 2, Ci was generated as the minimum of Uniform(1, τ + 2) and τ . In Scenario 3,
Ci was generated from Uniform(1, τ + 1) if Z2i = 0 and Exponential(1) + 1 if Z2i = 1, and
then truncated at τ . In Scenario 4, we set Ci = min(exp(γi), 100τ), which yielded Spearman
correlations between Ni(Ci)/Ci and Ci, ranging 0.05 ∼ 0.56. In Table 1, we fixed the baseline
intensity to Λ0(t) = 0.5 t for all scenarios, in order to demonstrate the dependence between
the censoring distribution and C-index, with the baseline intensity equal. In contrast, in
Table 2 Λ0(t) = νt differed across scenarios in order to demonstrate that similar C0 can result
from different censoring distributions. Specifically, ν was tuned to yield similar numbers of
comparable pairs among the different censoring scenarios; we set ν = 0.5 for Scenario 1,
ν = 1 for Scenario 2, and ν = 1.4 for Scenario 3. For each setting, the true value of C0
was approximated based on a random sample of {Zi, N∗i (·), Ci} from one hundred thousand
individuals under true β0. To compute Cˆ, we first fitted a proportional rates model, then
used the resulting estimates βˆ to compute the proposed C-index estimate from (4). Standard
errors were computed under the proposed perturbation resampling methods.
Simulation results based on 1000 replications and n = 200 are presented in Tables 1 - 3.
In each table, Bias equals the difference between the average of the C-index estimates and
the true value; SD is the empirical standard deviation of the parameter estimates; SEE is
the average of the standard error estimates; and CP is the coverage probability of the 95%
confidence intervals.
From Tables 1 - 2, we notice that C0 strictly decreased as: the baseline intensity (ν)
decreased; the frailty variance (V ) increased; and the marginal proportion of subjects with
zero observed events (P{Ni(τ) = 0}) increased. However, C0 appeared only to be weakly
dependent on the percentage of censored (unobserved) N∗(τ) and the specific form of cen-
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soring mechanism. In all settings we considered, including the outcome-dependent censoring
scenario, the proposed estimator showed good performance. That is, the Cˆ estimates were
unbiased, while the standard error estimates closely approximated the true variability in Cˆ.
In turn, CPs were close to the nominal level.
We also investigated the finite sample properties of the proposed Cˆ when the propor-
tional means model assumption was violated. Under this scenario, the additive rates model
E[dN∗i (t)|Zi, γi] = {m0+γi+β1Z1i+β2Z2i}dt with m0 = 0.2 (Schaubel et al., 2006) was used
to generate recurrent event times, with the proportional means model used to develop a risk
score and to calculate the C-index. Table 3 shows that, even if the risk score development
model was different from the data generation model, Cˆ accurately estimated C0 with a
small sample size, where C0 is defined with respect to the assumed risk score development
model. The standard deviations of Cˆ were well estimated using the nonparametric bootstrap
method, whereas the model-based standard error estimates using equation (6) were slightly
over-estimated when the frailty variance increased to V = 1.
[Table 1 about here.]
[Table 2 about here.]
[Table 3 about here.]
4. Application
Dialysis Outcomes and Practice Patterns Study (DOPPS). The DOPPS is a prospective
multi-center international study of prevalent hemodialysis patients. Patients within each
DOPPS facility were randomly sampled, with the intention of preserving the key charac-
teristics of the base population of the selected facilities. Data were obtained from Arbor
Research Collaborative for Health, which founded and serves a data coordinating center for
the DOPPS. We analyzed data from DOPPS Phase 5, the most recently completed phase
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of the study. Patients were recruited for Phase 5 between 2012 and 2015. The total sample
size included approximately 17,000 prevalent hemodialysis patients, from 465 facilities in
19 different countries. Active follow-up began at entry to DOPPS and continued until the
earliest of death, receipt of a kidney transplant, switch to peritoneal dialysis, transfer to
another facility, or the end of the observation period (12/31/2015). Further detail regarding
the DOPPS is available in Robinson et al. (2012).
In the interests of constructing a cohort of (approximately) incident end-stage renal disease
patients, we included only patients with6 6 months on dialysis at DOPPS entry (n = 3, 692).
Our study cohort included patients from the following countries: Belgium, Canada, China,
Germany, the six Gulf Cooperation Council (GCC) countries (Bahrain, Qatar, Kuwait,
Oman, Saudi Arabia, and United Arab Emirates), Italy, Japan, Spain, Sweden and the
United Kingdom.
Objectives of Analysis. The recurrent event of interest is hospitalization (i.e., hospital
admission). Among the more than 140 peer-reviewed articles featuring the analysis of DOPPS
data, relatively few have involved evaluating the ability of the assumed regression model
to discriminate patients with respect to event risk. Motivated by this issue, we sought to
quantify the improvement in discrimination resulting from adjusting for country, and further
adjusting for an extensive list of comorbidity indicators. That is, we evaluate the improvement
in the model based on the successive inclusion of covariates representing key distinguishing
characteristics of DOPPS: its international component, and collection of information on an
extensive list of comorbid conditions.
Analysis of DOPPS Data. Of the n = 3, 692 incident patients identified, 49% and 46%
were dialyzing with fistulas and catheters, respectively, at the study entry. A mean follow-up
time was 14 months, and maximum follow-up was 4 years. In terms of hospitalizations, 55%
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of patients were never admitted, 20% were admitted once, 11% were admitted twice, and
14% were hospitalized >2 times.
Three different sets of potential confounding factors were considered for the risk of hos-
pitalization. Model 1 was the most basic model, and included age (15-year increments), sex
(ref: male), height (10-cm increments), duration of dialysis at DOPPS entry (ref: 3-6 month),
and two separate indicators for a graft and a catheter user (ref: fistula). In addition to the
afore-listed covariates, Model 2 further adjusted for country, while Model 3 adjusted for
country and the following 8 comorbid conditions: congestive heart failure, coronary artery
disease, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary
disease, diabetes, cancer, and neurological disorder. In Table 4, the estimated regression
coefficients for predictors in Model 3 are presented. The hospitalization rate was significantly
increased for patients with a graft or a catheter serving as vascular access, relative to arterial
vascular fistula (AVF). Each of the comorbid conditions was associated with a significantly
increased hospitalization rate. Canada, China, Italy and Spain each had significantly lower
hospitalization rates related to the United States. Three countries had significantly higher
hospitalization rates than the U.S.: Belgium, Germany and Sweden, with the latter estimated
to have the highest rate.
In Table 5, we compare C-index estimates for models with and without comorbidity and
country. The standard error estimate of Cˆ using the perturbation resampling method (see
Model-based SE) were compared with the nonparametric bootstrap estimate (see Robust
SE). Risk discrimination based on different models was compared through Cˆ∆, the difference
in Cˆ. To estimate the variance of Cˆ∆, we recommend using the nonparametric bootstrap
method since its validity does not require correctness of either of the models being compared.
Suppose Cˆ
(b)
∆ is the difference in C-index estimates obtained from the bth set of random
subjects. Then, the the robust SE of Cˆ∆ was obtained as the sample standard deviation of
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B = 100 realizations of Cˆ
(b)
∆ . A two-sided 95% confidence interval Cˆ∆ ± 1.96 ∗ SE(Cˆ∆) can
be used for the test for no difference in Cˆs.
Table 5 shows that Model 1, having not adjusted for country and comorbidities, resulted
in Cˆ = 0.596. This implies that 59.6% of pairs were concordant, in the sense that pa-
tient predicted to have higher hospitalization risk had more hospital admissions during the
sub-interval of overlapping follow-up. By additionally including country in the model, the
discriminatory power of Model 2 improved to 63% concordance, and the improvement was
statistically significant at the level of .05 (Cˆ∆ = 3.4%, SE = 0.6%). Finally, Cˆ of Model
3 improved to 65.4% concordance by further adjusting for comorbidities; and Model 3 was
significantly better than Model 2 (Cˆ∆ = 2.5%, SE = 0.5%).
For comparison purposes, we also carried out a time-to-first event analysis, with the end-
point re-defined as the time to first hospital admission. We observed the CˆS decreased from
Cˆ when the time-to-first-hospitalization was used only (CˆS = 0.585, SE = 0.008 for Model
1; CˆS = 0.618, SE = 0.008 for Model 2; CˆS = 0.641, SE = 0.008 for Model 3). This can
be explained by the fact that the use of recurrent event data allowed a longer common
observation period for risk comparisons (i.e., Ci ∧ Cj was longer than Xi ∧ Xj), which, in
turn, increased the corresponding model’s discriminatory power.
For those countries with more than 300 patients (Canada, Germany, Japan and USA), we
have also carried out separate analyses by county and evaluated the country-specific models
using the proposed C-index. The country-specific models included the same set of predictors
(i.e., Model 1 + comorbidities), but the resulting C-index estimates were varying country
to country (Table 6). In particular, the model for Germany obtained the highest Cˆ = 0.654
(best in predicting a higher risk), whereas the model for USA yielded a noticeably lower
Cˆ = 0.619, comparing to Cˆ = 0.644 for Canada and Cˆ = 0.645 for Japan. The standard
error estimate for Cˆ consistently reduced as sample size increased.
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[Table 4 about here.]
[Table 5 about here.]
[Table 6 about here.]
5. Discussion
Using counting processes, we have developed a C-index applicable to recurrent event data.
Theoretical properties are derived under an assumed proportional rates model (Lin et al.,
2000). The proposed C-index can be interpreted as the fraction of concordant subject-pairs,
where concordance refers to the within-pair ordering of the linear predictor and the observed
number of events for the follow-up subinterval during which both subject are uncensored. The
measure reflects a rate model’s ability to discriminate subjects with respect to recurrent event
risk. The proposed C-index performed well in simulation studies. The use of perturbation
methods (in lieu of traditional closed-form variance computation) permits relatively quick
estimation of confidence intervals, and hence makes the proposed inference procedures quite
attractive computationally; this is an important property in the big data era.
In our analysis of hospitalization rates using data from Phase 5 of the Dialysis Outcomes
and Practice Patterns Study (DOPPS), Cˆ increased by approximately 0.03 upon the addition
of country to a model which contained demographic and basic clinical covariates, and then
increased by an additional ≈ 0.02 upon further adjustment for comorbidity indicators. These
increases are somewhat contrary to the reputation for insensitivity the C-index has earned
in the context of standard survival data. Further study would reveal whether this is due to
the nature of recurrent event data in general, or whether our real-data example is somewhat
of an anomaly. It is true that the C-index tends to be higher for logistic regression models
than for survival models, owing mostly to the latter being subject to censoring; e.g., see
Sharma et al. (2016). For right censored survival data, for a subject-pair to be usable, at
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least one member of the pair has to be an observed death. In contrast, for right censored
recurrent event data, all untied subject-pairs are usable, albeit during the subinterval of
overlapping follow-up (i.e., until the minimum of the two censoring times within-pair). In
the DOPPS analysis, we actually observed that C-index with recurrent event data was higher
than that with survival data. From this perspective, recurrent event data may lie in between
survival data and binary responses with respect to the typical sensitivity of the C-index to
the addition of model covariates.
6. Supplementary Materials
The source R codes for implementing the proposed methods are available with this paper at
the Biometrics website on Wiley Online Library.
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Appendix: Asymptotic properties of Cˆ(βˆ)
To establish asymptotic properties of Cˆ(βˆ), we impose the same regularity conditions as
those in Section 2 of Lin et al. (2000). We begin with the consistency of Cˆ(βˆ). We define the
denominator of Cˆ(β) by
πˆ = n−2
n∑
i=1
n∑
j=1
I{Ni(Ci ∧ Cj) > Nj(Ci ∧ Cj)} = n−2
n∑
i=1
n∑
j=1
Iij.
Given that πˆ (as well as Cˆ(β)) is a functional of a U-process indexed by a class of indicator
functions, by a uniform law of large numbers for U-processes (Nolan and Pollard, 1987) and
the independent assumption between N∗ and C, we can show πˆ converges to Pr{N∗1 (C1) >
N∗2 (C1), C1 6 C2} in probability. Following the strong consistency of βˆ (Lin et al., 2000)
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and a uniform law of large numbers for U-processes of Cˆ(β), we can then show that
Cˆ(βˆ) = n−2
n∑
i=1
n∑
j=1
IijI(βˆ
′
Zi > βˆ
′
Zj)/{n−2
n∑
i=1
n∑
j=1
Iij}
converges to C0 = Pr{β′0Z1 > β′0Z2 |N∗1 (C1) > N∗2 (C1), C1 6 C2} in probability.
To show the limiting distribution of W , we decompose W into
W = √n {Cˆ(β0)− C0}+
√
n {Cˆ(βˆ)− Cˆ(β0)}. (8)
By a functional central limit theorem for U-processes (Nolan and Pollard, 1988), the first
term in (8) is asymptotically equivalent to, for a fixed β0,
√
n {Cˆ(β0)− C0} = n−3/2
n∑
i=1
n∑
j=1
Iij{I(β′0Zi > β
′
0Zj)− C0}/{n−2
n∑
i=1
n∑
j=1
Iij}
≈ √n
(
n
2
)
−1∑
i<j
{Vij(β0) + Vji(β0)}/2,
where Vij(β0) = Iij{I(β
′
0Zi > β
′
0Zj) − C0}[Pr{N∗1 (C1) > N∗2 (C1), C1 6 C2}]−1. Next, we
show that the second term in (8) is asymptotically equivalent to
√
n {Cˆ(βˆ)− Cˆ(β0)} = ∂βC0
√
n (βˆ − β0) + op(1),
where ∂βC0 is an approximation of the first derivative of C0 with respect to β0. The proof
starts from the fact that for an indicator function, we can find at least one continuously
differentiable approximation function. For simplicity, let’s consider an indicator function
I(β) = 1 if β > 0, and I(β) = 0 otherwise. Then, there exists a continuously differentiable
function L(β, ν) such that, ∀β ∈ R, it holds that limν→∞ L(β, ν) = I(β), where
L(β, ν) =
1
1 + exp{−ν(β + 1/√ν)} .
The first derivative of L(β, ν) with respect to β is ∂L(β, ν)/∂β = ν exp{−ν(β + 1/√ν)}
[1+exp{−ν(β+1/√ν)}]−2. As ν goes to positive infinity, the limit of ∂L(β, ν)/∂β approaches
0 for any fixed β. Limits of higher order derivatives are bounded as well. By analogical
arguments, approximations of the first derivatives of C0 and Cˆ(β0) exist, and they are
denoted as ∂βC0 and ∂βCˆ(β0), respectively. Now, applying the Taylor series expansion at β0
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from the consistency of βˆ yields
√
n {Cˆ(βˆ)− Cˆ(β0)} ≈ ∂βCˆ(β0)
√
n(βˆ − β0) + op(1).
We then show ∂βCˆ(β0) converges to ∂βC0 in probability from the consistency of Cˆ(β) and
the continuity of C0. Note that the asymptotic expansion of
√
n (βˆ−β0) shown by Lin et al.
(2000) can be re-written with respect to a U-statistic as follows:
√
n (βˆ − β0) ≈ n−1/2
n∑
i=1
A−1(β0)Ui(β0)
=
√
n
(
n
2
)
−1∑
i<j
A−1(β0){Ui(β0) + Uj(β0)}/2.
Finally, it then follows, by a functional central limit theorem for U-processes, that
W = √n
(
n
2
)
−1∑
i<j
W˜ij + op(1) (9)
converges in distribution to a Gaussian process with zero mean and variance σ2 ≡ E(W˜12W˜13),
where W˜ij = {Vij(β0) + Vji(β0)}/2 + C˙0A−1(β0){Ui(β0) + Uj(β0)}/2.
To approximate the distribution of W , we simulate a number of realizations from W ∗,
given by
W ∗ =
√
n
(
n
2
)
−1∑
i<j
{Vij(βˆ) + Vji(βˆ)} ǫiǫj/2 +
√
n {Cˆ(β∗)− Cˆ(βˆ)},
by repeatedly sampling {ǫi; i = 1, . . . , n}, conditioning on the observed data {Ni(t), Ci,Zi}.
Note that, from the consistency in βˆ and Cˆ, the limiting quantity of Vij(βˆ) is Vij(β0). After
replacing all unknown quantities in W with their respective consistent estimates and limits,
the only random components in W ∗ are the i.i.d. {ǫi} that has mean one and variance one.
Therefore, the conditional distribution of W ∗ given {Ni(t), Ci,Zi} has the same limiting
distribution as W .
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Table 1
Simulation results for the proposed Cˆ based on n = 200. The baseline intensity function was set as Λ0(t) = 0.5 t
regardless of censoring scenarios.
V a Censb P{Ni(τ) = 0}c True Bias SD SEE CP
Complete Follow-up
0.01 0 % 8.9 % 0.804 0.002 0.016 0.017 94.7
0.25 0 % 12.9 % 0.745 0.001 0.020 0.020 95.5
0.5 0 % 17.5 % 0.707 0.002 0.022 0.022 94.9
1.0 0 % 25.4 % 0.667 -0.002 0.024 0.025 96.3
Completely independent Censoring
0.01 24.3 % 17.8 % 0.770 0.001 0.020 0.020 94.2
0.25 23.1 % 21.9 % 0.729 0.001 0.022 0.022 94.0
0.5 21.9 % 26.2 % 0.702 0.000 0.024 0.024 94.1
1.0 19.9 % 33.6 % 0.666 0.001 0.026 0.027 95.1
Covariate-dependent Censoring
0.01 42.6 % 25.8 % 0.749 0.001 0.022 0.022 94.8
0.25 40.9 % 30.0 % 0.717 0.003 0.024 0.025 93.9
0.5 38.7 % 34.0 % 0.696 0.002 0.025 0.026 94.7
1.0 35.2 % 40.7 % 0.667 0.001 0.028 0.028 94.6
Outcome-dependent Censoring
0.01 41.3 % 21.8 % 0.765 0.003 0.020 0.021 95.4
0.25 35.9 % 29.4 % 0.729 0.001 0.023 0.024 95.6
0.5 33.6 % 35.2 % 0.707 0.002 0.025 0.025 94.6
1.0 29.8 % 43.0 % 0.681 0.001 0.027 0.028 95.1
a the variance of frailty γi used for generating repeated events from model (7)
b 1− E[Ni(τ)]/E[N
∗
i
(τ)]
c the marginal proportion of subjects with zero observed events
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Table 2
Simulation results for the proposed Cˆ based on n = 200. The baseline intensity function Λ0(t) = νt was varying with
different censoring scenarios.
ν V a Censb P{Ni(τ) = 0}c True Bias SD SEE CP
Complete Follow-up
0.5 0.01 0 % 8.9 % 0.804 0.002 0.016 0.017 94.7
0.25 0 % 12.9 % 0.745 0.001 0.020 0.020 95.5
0.5 0 % 17.5 % 0.707 0.002 0.022 0.022 94.9
1.0 0 % 25.4 % 0.667 -0.002 0.024 0.025 96.3
Completely independent Censoring
1.0 0.01 26.2 % 6.7 % 0.809 0.000 0.015 0.015 94.3
0.25 25.6 % 9.9 % 0.746 0.001 0.019 0.019 95.0
0.5 24.6 % 13.9 % 0.712 -0.002 0.021 0.022 95.3
1.0 22.6 % 21.2 % 0.664 0.000 0.023 0.024 95.2
Covariate-dependent Censoring
1.4 0.01 46.0 % 6.2 % 0.805 -0.001 0.015 0.016 95.9
0.25 45.3 % 9.6 % 0.744 0.001 0.019 0.020 94.2
0.5 44.2 % 13.9 % 0.708 0.001 0.021 0.022 95.3
1.0 41.2 % 21.2 % 0.664 0.001 0.023 0.025 95.5
a the variance of frailty γi used for generating repeated events from model (7)
b 1− E[Ni(τ)]/E[N
∗
i
(τ)]
c the marginal proportion of subjects with zero observed events
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Table 3
Simulation results for the proposed Cˆ based on n = 200 under the misspecified risk prediction model. The baseline
intensity function was set as Λ0(t) = 0.2 t regardless of censoring scenarios.
Model-based Robust
V a Censb P{Ni(τ) = 0}c True Bias SD SEE CP SEE CP
Complete Follow-up
0.01 0 % 0.0 % 0.691 0.002 0.021 0.022 95.0 0.021 93.7
0.25 0 % 0.2 % 0.659 0.003 0.023 0.024 94.9 0.023 94.7
0.5 0 % 0.5 % 0.645 0.003 0.024 0.025 95.1 0.023 92.5
1.0 0 % 1.0 % 0.630 0.004 0.024 0.028 96.4 0.024 93.4
Completely independent Censoring
0.01 26.6 % 1.5 % 0.656 0.003 0.022 0.023 94.5 0.022 93.1
0.25 26.4 % 2.1 % 0.637 0.002 0.024 0.024 94.5 0.023 94.8
0.5 26.7 % 2.6 % 0.627 0.003 0.024 0.026 94.6 0.024 94.9
1.0 26.6 % 3.4 % 0.618 0.004 0.024 0.029 97.1 0.025 94.1
Covariate-dependent Censoring
0.01 46.1 % 3.2 % 0.633 0.003 0.024 0.025 95.8 0.024 94.3
0.25 46.2 % 3.9 % 0.622 0.002 0.025 0.026 95.4 0.024 95.2
0.5 46.1 % 4.8 % 0.615 0.004 0.024 0.027 97.4 0.025 94.8
1.0 45.9 % 6.1 % 0.610 0.004 0.024 0.030 96.8 0.026 94.1
a the variance of frailty γi used for generating repeated events from model (7)
b 1− E[Ni(τ)]/E[N
∗
i
(τ)]
c the marginal proportion of subjects with zero observed events
Page 24 of 27Biometrics
Au
tho
r M
an
us
cri
pt
24 Biometrics, 000 0000
Table 4
Analysis of DOPPS data: Estimated covariate effects on hospitalization rates (based on Model 3).
Covariate βˆ SE p-value exp{βˆ}
Age (per 15 yrs) -0.024 0.030 0.425 0.98
Female 0.100 0.065 0.127 1.11
Height (per 10 cm) 0.009 0.036 0.804 1.01
Dialysis 6 3 monthsa 0.027 0.056 0.626 1.03
Graft (ref: AVF) 0.510 0.111 <.0001 1.67
Catheter (ref: AVF) 0.454 0.058 <.0001 1.57
CHF 0.165 0.061 0.007 1.18
CAD 0.122 0.058 0.035 1.13
CeVD 0.142 0.060 0.019 1.15
PVD 0.163 0.059 0.006 1.18
COPD 0.221 0.071 0.002 1.25
Diabetes -0.001 0.052 0.984 1.00
Cancer 0.189 0.073 0.010 1.21
Neurological disease 0.292 0.076 0.0001 1.34
Belgium (ref: U.S.) 0.381 0.097 0.0001 1.46
Canada (ref: U.S.) -0.227 0.108 0.036 0.77
China (ref: U.S.) -0.386 0.191 0.043 0.68
Germany (ref: U.S.) 0.336 0.082 <.0001 1.40
Gulf (ref: U.S.) -0.181 0.115 0.115 0.83
Italy (ref: U.S.) -0.329 0.115 0.004 0.72
Japan (ref: U.S.) 0.001 0.097 0.996 1.00
Spain (ref: U.S.) -0.368 0.113 0.001 0.69
Sweden (ref: U.S.) 0.750 0.113 <.0001 2.12
UK (ref: U.S.) 0.134 0.111 0.226 1.14
Abbreviations: SE, standard error estimate; AVF, arterial vascular fistula; CHF,
congestive heart failure; CAD, coronary artery disease; CeVD, cerebrovascular disease;
PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; UK,
United Kingdom.
a Time since initiating dialysis as of DOPPS entry; ref: (3, 6] months.
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Table 5
Analysis of DOPPS data: Comparison of Cˆ for various models
Model-based Robust
Model Cˆ SE SE
1 0.596 0.008 0.007
2 0.630 0.008 0.008
3 0.654 0.008 0.008
Model comparison Cˆ∆ Robust SE
2 vs. 1 0.034 0.006
3 vs. 2 0.025 0.005
Model 1 included age, sex, height, duration of dialysis, vascular access
(AV fistula, AV graft, or tunneled catheter). Model 2 included all pre-
dictors in Model 1 + country (Belgium, Canada, China, Germany, Gulf,
Italy, Japan, Spain, Sweden, UK, or USA). Model 3 included all predictors
in Model 2 + comorbidity (congestive heart failure, coronary artery
disease, cerebrovascular disease, peripheral vascular disease, chronic ob-
structive pulmonary disease, diabetes, cancer, and neurological disorder).
SE is the standard error estimate.
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Table 6
Analysis of DOPPS data by country using Model 1 + comorbidities.
Hospitalization Model-based Robust
Country Sample Sizea Rateb Cˆ SE SE
Canada 315 6.7 0.644 0.030 0.030
Germany 359 10.8 0.654 0.023 0.023
Japan 631 5.0 0.645 0.022 0.021
USA 1,047 7.7 0.619 0.018 0.015
All 3,692 7.3 0.654 0.008 0.008
SE, standard error estimate
a patients
b per 100 patient-months
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